SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-030063
Filing Date
2019-08-07
Accepted
2019-08-07 16:11:20
Documents
62
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kzr-10q_20190630.htm 10-Q 2249785
2 EX-31.1 kzr-ex311_9.htm EX-31.1 19887
3 EX-31.2 kzr-ex312_6.htm EX-31.2 20031
4 EX-32.1 kzr-ex321_8.htm EX-32.1 9205
5 GRAPHIC ghuib4klkzy3000001.jpg GRAPHIC 39595
  Complete submission text file 0001564590-19-030063.txt   6954545

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kzr-20190630.xml EX-101.INS 1489066
7 XBRL TAXONOMY EXTENSION SCHEMA kzr-20190630.xsd EX-101.SCH 43097
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kzr-20190630_cal.xml EX-101.CAL 47974
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kzr-20190630_def.xml EX-101.DEF 111586
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kzr-20190630_lab.xml EX-101.LAB 348078
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kzr-20190630_pre.xml EX-101.PRE 264785
Mailing Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Filer) CIK: 0001645666 (see all company filings)

IRS No.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38542 | Film No.: 191005566
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences